84184-51-0

Basic information

• Product Name: (2E)-3-[4-(PhenylMethoxy)phenyl]-2-propenoic Acid Methyl Ester
• Synonyms: (2E)-3-[4-(PhenylMethoxy)phenyl]-2-propenoic Acid Methyl Ester;Methyl 4-Benzyloxy CinnaMate;methyl (E)-3-(4-benzyloxyphenyl)prop-2-enoate;Methyl 3-[4-(benzyloxy)phenyl]acrylate, 98%
• CAS NO: 84184-51-0
• Molecular Formula: C₁₇H₁₆O₃
• Molecular Weight: 268.30714
• Product Categories: Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals
• Mol File: 84184-51-0.mol
• Article Data: 23

Chemical Properties

• Appearance: /
• Solubility: Dichloromethane
• CAS DataBase Reference: (2E)-3-[4-(PhenylMethoxy)phenyl]-2-propenoic Acid Methyl Ester(CAS DataBase Reference)
• NIST Chemistry Reference: (2E)-3-[4-(PhenylMethoxy)phenyl]-2-propenoic Acid Methyl Ester(84184-51-0)
• EPA Substance Registry System: (2E)-3-[4-(PhenylMethoxy)phenyl]-2-propenoic Acid Methyl Ester(84184-51-0)

Safety Data

• Hazardous Substances Data: 84184-51-0(Hazardous Substances Data)

Usage

Chemical Properties

Off-White Solid

Uses

Methyl 4-Benzyloxy Cinnamate is cinnamic acid derivative used in structure-antifungal activity relationship study against Aspergillus flavus, Aspergillus terreus, and Aspergillus niger. An antifungal agent.

Upstream product

• 4397-53-9 p-benzyloxybenzaldehyde 
• 5927-18-4 trimethyl phosphonoacetate 
• 6272-45-3 (E)-4-benzyloxycinnamic acid 
• 77-78-1 dimethyl sulfate 
• 292638-85-8 acrylic acid methyl ester 
• 21204-67-1 methyl (triphenylphosphoranylidene)acetate 
• 180250-67-3 benzyl (E)-3-(4-benzyloxyphenyl)prop-2-enoate 
• 7400-08-0 p-Coumaric Acid 
• 6373-46-2 p-benzyloxyaniline 
• 123-08-0 4-hydroxy-benzaldehyde 
• 100-39-0 benzyl bromide 
• 3943-97-3 methyl 4-hydroxycinnamate 
• 100-44-7 benzyl chloride 
• 67-56-1 methanol 

Downstream Products

• 134430-95-8 methyl (3S,αR)-3-(N-benzyl-N-α-methylbenzylamino)-3-(4-benzyloxyphenyl)propanoate 
• 3943-97-3 methyl 4-hydroxycinnamate 
• 84184-52-1 (E)-3-(4-(benzyloxy)phenyl)prop-2-en-1-ol 
• 77503-07-2 3-Ethylsulfanyl-3-(4-hydroxy-phenyl)-propionic acid methyl ester 
• 225517-50-0 (R)-3-(4-Benzyloxy-phenyl)-3-[benzyl-((S)-1-phenyl-ethyl)-amino]-propionic acid methyl ester 
• 87030-12-4 4-benzyloxycinnamyl alcohol 
• 6272-45-3 4-benzyloxycinnamic acid 
• 77092-63-8 2-(p-hydroxyphenylpropionoyloxy)(a)-4-(3',4'-dimethoxyphenyl)(e)-trans-quinolizidine 
• 71480-97-2 2-(p-methoxyphenylpropionoyloxy)(a)-4-(3',4'-dimethoxyphenyl)(e)-trans-quinolizidine 
• 77092-60-5 2-(p-benzyloxyphenylpropionoyloxy)(a)-4-(3',4'-dimethoxyphenyl)(e)-trans-quinolizidine 
• 10183-64-9 Decinin 
• 1239861-07-4 C₁₄H₁₈O₅ 
• 1193357-61-7 C₃₄H₃₃IO₇ 
• 1193357-62-8 C₃₄H₃₄BrIO₇ 

Relevant articles and documents

ARYL CYCLOPROPYL-AMINO-ISOQUINOLINYL AMIDE COMPOUNDS

Provided herein are arylcyclopropyl amino-isoquinoline amide compounds. In particular, the disclosure provides compounds that affect the function of kinases in a cell and that are useful as therapeutic agents or with therapeutic agents. The compounds of t

Stellatolides, a new cyclodepsipeptide family from the sponge ecionemia acervus: Isolation, solid-phase total synthesis, and full structural assignment of stellatolide a

The marine environment is a rich source of metabolites with potential therapeutic properties and applications for humans. Here we describe the first isolation, solid-phase total synthesis, and full structural assignment of a new class of cyclodepsipeptides from the Madagascan sponge Ecionemia acervus that shows in vitro cytotoxic activities at submicromolar concentrations. Seven structures belonging to a new family of compounds, given the general name stellatolides, were characterized. The sequence and stereochemistry of all the amino acids in these molecules were established by a combination of spectroscopic analysis, chemical degradation, and derivatization studies. Furthermore, the complete structure of stellatolide A was confirmed by an efficient solid-phase method for the first total synthesis and the full structural assignment of this molecule, including the asymmetric synthesis of the unique B-hydroxy acid moiety (Z)-3-hydroxy-6,8-dimethylnon-4-enoic acid.

METHODS OF TREATMENT USING ARYLCYCLOPROPYLAMINE COMPOUNDS

Described herein are methods of treating Parkinson's disease using arylcyclopropylamine compounds.